Max Planck Society

EQS-News: World's largest radio telescope – Listen to the universe

Retrieved on: 
Wednesday, March 13, 2024

Extraordinary: The radio dishes are gradually being integrated into the SKA Square Kilometre Array, an international project to build the world's largest radio telescope with sites in southern Africa and in Australia.

Key Points: 
  • Extraordinary: The radio dishes are gradually being integrated into the SKA Square Kilometre Array, an international project to build the world's largest radio telescope with sites in southern Africa and in Australia.
  • This is an achievement of partners from science and industry, nationally and internationally.
  • We now have our focus on series production," says Fabrice Scheid, Managing Director of OHB Digital Connect's Mainz site.
  • The individual segments of the radio dishes are delivered to Cape Town by ship, transported to the desert with heavy equipment and assembled on site.

What’s with the Extra Day? A College of Charleston Professor Explains Lear Year.

Retrieved on: 
Tuesday, February 27, 2024

Our calendar year is based on the time it takes the Earth to complete one full orbit around the Sun.

Key Points: 
  • Our calendar year is based on the time it takes the Earth to complete one full orbit around the Sun.
  • So, in a non-leap year, after 365 days, the Earth would be slightly behind where it started relative to the Sun.
  • The Julian calendar added an extra day at the end of the year every four years.
  • Later on, two extra months were added to the calendar with February being made the last month of the year.

15th International Workshop on Advanced Materials Kicks off in Ras Al Khaimah

Retrieved on: 
Tuesday, February 20, 2024

Today, the 15th International Workshop on Advanced Materials (IWAM) organised by the Ras Al Khaimah Center for Advanced Materials (RAKCAM) kicks off at the Mövenpick Resort on Al Marjan Island.

Key Points: 
  • Today, the 15th International Workshop on Advanced Materials (IWAM) organised by the Ras Al Khaimah Center for Advanced Materials (RAKCAM) kicks off at the Mövenpick Resort on Al Marjan Island.
  • View the full release here: https://www.businesswire.com/news/home/20240219081040/en/
    HH Saud bin Saqr attends the opening of the 15th #IWAMRasAlKhaimah and takes part in a fireside discussion that highlights Ras Al Khaimah’s commitment to scientific progress and innovation.
  • The event is again being held under the patronage of His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, who is participating in a fireside discussion about the importance of advanced materials in solving the world’s greatest challenges.
  • Sir Anthony Cheetham, Chairman of Ras Al Khaimah Center for Advanced Materials, commented: “His Highness Sheikh Saud is dedicated to leveraging education and science as drivers of innovations that contribute to humanity’s advancement - and committed to advancing the field of materials science.

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

Retrieved on: 
Tuesday, February 13, 2024

JERUSALEM, Feb. 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as Head of Business Development and Sales.

Key Points: 
  • JERUSALEM, Feb. 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as Head of Business Development and Sales.
  • Scinai's broad pharmaceutical development experience, along with its end-to-end biologics drug development and GMP manufacturing facility, drove the Q3 2023 launch of Scinai Bioservices, a boutique end-to-end CDMO business unit, to assist biotech companies efficiently bring their products to market.
  • In addition to expanding the CDMO's business development and sales activities, Halpert will support partnering and out-licensing activities with mid and large cap pharma companies with which Scinai plans on bringing the NanoAbs through clinical trials and towards commercialization.
  • Halpert commented, "I am thrilled to join Scinai where I'll be leading business development and sales of our state-of-the-art end-to-end CDMO services in the global biotech arena.

As the war in Gaza continues, Germany’s unstinting defence of Israel has unleashed a culture war that has just reached Australia

Retrieved on: 
Tuesday, February 13, 2024

His work led him to being offered a stint at Germany’s prestigious Max Planck Institute for Social Anthropology.

Key Points: 
  • His work led him to being offered a stint at Germany’s prestigious Max Planck Institute for Social Anthropology.
  • This came less than two months after the Max Planck Foundation, with war in Gaza raging, had announced “additional funding for German-Israeli collaborations”.
  • What to me is a fair, intellectual critique of Israel, for them is “antisemitism according to the law in Germany”.

A political ideal

  • As he succinctly writes:
    I have a political ideal that I have always struggled for regarding Israel/Palestine.
  • It is the ideal of a multi-religious society made from
    Christians, Muslims and Jews living together on that land.
  • I have a political ideal that I have always struggled for regarding Israel/Palestine.
  • It is the ideal of a multi-religious society made from
    Christians, Muslims and Jews living together on that land.
  • His criticism of current Israeli policy, he insists, stems from the Netanyahu government’s determination to “work against such a goal”.

Self-imposed red lines

  • It is worth pointing out that it is not just happening in Germany.
  • Universities in the United States are under siege from students and community groups variously accusing them of both antisemitism and Islamophobia.
  • Largely, however, what’s happening in Germany is a result of some self-imposed red lines the German press, the German courts and the German parliament have imposed on public debate.
  • Rather, it is a result of Germany’s current belief that its genocidal, antisemitic Nazi past implies future unwavering support for Israel.
  • It might equally be said that Germany has a special responsibility to stridently oppose ethnic cleansing, war crimes and genocide wherever they occur.

Enough?

  • Sharp words from German government officials about the renewed Israeli campaign in Rafah suggest this might be possible.
  • The German Foreign Minister Annalena Baerbock warned recently “the people of Gaza cannot vanish into thin air”.


Matt Fitzpatrick receives funding from the Australian Research Council.

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize

Retrieved on: 
Thursday, January 25, 2024

JERUSALEM, Jan. 25, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products, congratulates the Company's co-lead scientific research collaborator Professor Dr. Dirk Görlich on being awarded the 2024 Louis-Jeantet Prize.

Key Points: 
  • JERUSALEM, Jan. 25, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products, congratulates the Company's co-lead scientific research collaborator Professor Dr. Dirk Görlich on being awarded the 2024 Louis-Jeantet Prize.
  • Görlich serves as a director of the Max Planck Institute for Multidisciplinary Sciences (MPI-NAT).
  • According to MPI-NAT, Görlich has received several other scientific awards including the Heinz Maier-Leibnitz Prize, the EMBO Gold Medal, the Alfried Krupp Prize, the WLA Prize 2022, and the Animal Welfare Research Prize of the German Federal Ministry of Food and Agriculture.
  • Amir Reichman, Scinai's CEO, commented, "On behalf of Scinai's team, I offer sincere congratulations to Dirk on being awarded the 2024 Louis-Jeantet Prize.

HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization

Retrieved on: 
Tuesday, January 16, 2024

Dr. Winderlich has rich experience leading multiple candidates through the drug development process to product approval in the United States and in Europe.

Key Points: 
  • Dr. Winderlich has rich experience leading multiple candidates through the drug development process to product approval in the United States and in Europe.
  • “We are pleased to bring our search for a capable clinical development leader to such a swift, successful resolution and welcome Mark to the team,” said Joern Aldag, Chief Executive Officer at HOOKIPA.
  • “Mark is a tremendous talent with rich experience across the drug development lifecycle.
  • Prior to Evotec, Dr. Winderlich spent more than 12 years in drug development at MorphoSys AG across various roles of increasing responsibility.

Ukraine recap: Zelensky's defiant new year speech foreshadows tough 2024 as government tightens conscription laws

Retrieved on: 
Thursday, January 4, 2024

Ukraine advances, Ukraine overcomes the path.

Key Points: 
  • Ukraine advances, Ukraine overcomes the path.
  • He said: “Ukrainians will cope with any energy shortage as they have no shortage of resilience and courage.
  • We defeated the darkness.” He took time to thank the Ukrainian people, talking up the country’s unity in the face of existential threat.
  • A refugee or a citizen?” The cold hard fact is that 2023 ended badly on the battlefield for Ukraine.
  • As late as the beginning of December Russia announced it was calling up another 170,000 troops.
  • In the meantime, a raft of new economic measures will increase the tax burden on ordinary Ukrainians, while at the same time radically reducing public spending.
  • Read more:
    Ukraine war increasingly seen as 'fought by the poor’, as Zelensky raises taxes and proposes strict mobilisation laws
  • You can also subscribe to our fortnightly recap of expert analysis of the conflict in Ukraine.
  • James Horncastle, of Simon Fraser University in British Columbia, meanwhile, believes that while Ukraine has suffered setbacks over the past six months or so, it can still prevail.
  • And then works out exactly what it will take in terms of western military aid to achieve that initial goal.

Do they know it’s Christmas?

  • Accordingly Ukrainians celebrated Easter and other important religious festivals and saints days at different times as well.
  • But in May 2023, the Ukrainian government took the decision to adopt the revised Julian – what we know as the Gregorian – calendar.
  • As Hann reports, the old religious calendar survived the Soviet era, but has now been swept away by decree from Kyiv.

Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors

Retrieved on: 
Monday, December 18, 2023

"We are delighted to welcome Peter to Enterome's Board of Directors," said Dr. Pierre Bélichard, Chief Executive Officer of Enterome.

Key Points: 
  • "We are delighted to welcome Peter to Enterome's Board of Directors," said Dr. Pierre Bélichard, Chief Executive Officer of Enterome.
  • "Peter is a recognized leader in the biotech industry and his extensive experience in corporate strategy and drug development will be invaluable to Enterome’s future growth and success.
  • I’d also like to thank Roger for his invaluable contributions to Enterome during his time on the Board."
  • Dr. Hirth possesses a wealth of experience and an exceptional track record in the biopharmaceutical industry.

Proxygen Announces Formation of Scientific Advisory Board

Retrieved on: 
Wednesday, November 15, 2023

VIENNA, Austria, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced the formation of the company’s scientific advisory board (SAB). The newly appointed SAB, which is comprised of highly regarded thought leaders in the emerging field of protein degradation, will offer scientific expertise and guidance to Proxygen as the company works to advance its internal molecular glue degrader programs toward clinical development. In addition to its internal programs, Proxygen is also actively engaged in strategic research collaboration and license agreements with Merck & Co (known as MSD outside the U.S. and Canada), Boehringer Ingelheim and Merck KGaA designed to jointly identify and develop novel molecular glue degraders.

Key Points: 
  • SAB Comprised of Pioneers in the Field of Protein Degradation, Including Unique Expertise in Roles of Ubiquitin Biology and Translational Medicine
    VIENNA, Austria, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced the formation of the company’s scientific advisory board (SAB).
  • Schulman and Draetta to the Proxygen team as key advisors and pair them with Drs.
  • Winter and Kubicek, who co-founded the company, based on their trailblazing research at CeMM,” said Bernd Boidol, Ph.D., chief executive officer of Proxygen.
  • By streamlining and fully integrating cutting-edge genomic, proteomic, and biochemical technologies, Proxygen has successfully developed a highly versatile glue degrader discovery engine.